Back to top

BMO Capital Sticks to Their Buy Rating for Gilead Sciences (GILD)

In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Gilead Sciences, with a price target of $174.00. According t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

General Mills, Inc. (GIS)